EA
CLMT icon

Ellsworth Advisors’s Calumet Specialty Products CLMT Stock Holding History

Ellsworth Advisors’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.16M Buy
+28,988
New +$974K 0.19% 102

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ellsworth Advisors's CLMT Position: Q2 2026 in Review

Ellsworth Advisors opened a new position in Calumet Specialty Products (CLMT) in Q2 2026: 28,988 shares worth $1.16M. The stake represents 0.19% of the portfolio and ranks #102 among its holdings.

188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • Ellsworth Advisors held 28,988 shares of Calumet Specialty Products worth $1.16M as of Q2 2026.
  • Calumet Specialty Products was a new Ellsworth Advisors position in Q2 2026.
  • Calumet Specialty Products made up 0.19% of Ellsworth Advisors's portfolio in Q2 2026, its #102 holding.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Ellsworth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.